- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/12 - Triazine radicals
Patent holdings for IPC class C07H 19/12
Total number of patents in this class: 128
10-year publication summary
|
12
|
6
|
11
|
5
|
7
|
9
|
12
|
5
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Idorsia Pharmaceuticals Ltd. | 333 |
6 |
| ScinoPharm Taiwan, Ltd. | 129 |
5 |
| Ohara Pharmaceutical Co., Ltd. | 38 |
5 |
| Merck Sharp & Dohme LLC | 3719 |
5 |
| Celgene Corporation | 1390 |
4 |
| Cilag AG | 12 |
4 |
| Emory University | 1693 |
4 |
| Gilead Sciences, Inc. | 2171 |
4 |
| Rome Therapeutics, Inc. | 32 |
4 |
| Epigenetics Pharma LLC | 6 |
3 |
| Southern Research Institute | 206 |
3 |
| Janssen Biopharma, Inc. | 36 |
3 |
| Massachusetts Institute of Technology | 10185 |
2 |
| Board of Regents, The University of Texas System | 6032 |
2 |
| The Johns Hopkins University | 5798 |
2 |
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 46 |
2 |
| Oregon Health & Science University | 754 |
2 |
| The Scripps Research Institute | 1346 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2965 |
2 |
| Universite de Montreal | 343 |
2 |
| Other owners | 62 |